Patent · US Active

Zika vaccines and immunogenic compositions, and methods of using the same

US11730802B2 · kind B2 · utility

0Cited by

1References

67Claims

0Family size

Assignee

Takeda Vaccines, Inc. · US

Inventors

Jill A. Livengood · Fort Collins, US
Hansi DEAN · Cambridge, US
Htay Htay HAN · Cambridge, US
Raman K. Rao · Palo Alto, US
Jackie Marks · Cambridge, US
Gary Dubin · Zürich, CH
Laurence DE MOERLOOZE · Zürich, CH
Hetal Patel · Libertyville, US
Sushma Kommareddy · Cambridge, US

Key dates

Filing date	Nov 5, 2018
Grant date	Aug 22, 2023
Priority date	—
Expiry date	Feb 3, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.), and methods of treatments and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.